Lv55
1010 积分 2023-03-31 加入
Fresh from the biotech pipeline: record-breaking FDA approvals
20天前
已完结
2023 FDA approvals
20天前
已完结
A single molecular descriptor to predict solution behavior oftherapeutic antibodies
1个月前
已完结
Utility of SPR technology in biotherapeutic development: Qualification for intended use
1个月前
已完结
Non-specificity as the sticky problem in therapeutic antibody development
2个月前
已完结
Predominant Autoantibody Production by Early Human B Cell Precursors
4个月前
已完结
Characterization of JNJ-80948543, a Novel CD79bxCD20xCD3 Trispecific T-Cell Redirecting Antibody for the Treatment of B-Cell Non-Hodgkin Lymphoma
4个月前
已关闭
Cancer cell metabolism and antitumour immunity
5个月前
已完结
T cell receptor (TCR) signaling in health and disease
5个月前
已完结
Localization, tissue biology and T cell state — implications for cancer immunotherapy
5个月前
已完结
皖公网安备34019202002308
